Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cells

Bone Marrow Transplantation

Volumn 22, Issue 7, 1998, Pages 631-637

  Rondelli, D ^a,d   Raspadori, D ^a   Anasetti, C ^b   Bandini, G ^a   Re, F ^a   Arpinati, M ^a   Stanzani, M ^a   Morelli, A ^c   Baccini, C ^c   Zaccaria, A ^c   Lemoli, R M ^a   Tura, S ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Fred Hutchinson Cancer Research Center   (United States)

^c SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

APC; IFN ; NK activity; Peripheral blood stem cells; T cell

Indexed keywords

ALLOANTIGEN; B7 ANTIGEN; CD1 ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD19 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ALLOIMMUNITY; ANTIGEN PRESENTATION; APHERESIS; ARTICLE; CELL FUNCTION; CLINICAL TRIAL; FLOW CYTOMETRY; HLA MATCHING; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; MIXED LEUKOCYTE CULTURE; MOBILIZATION; MONONUCLEAR CELL; NATURAL KILLER CELL; NORMAL HUMAN; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE; TARGET CELL;

EID: 18544403370     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701413     Document Type: Article

References (29)

1. Bensinger WI, Clift R, Martin P et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood 1996; 88: 2794-2801.
2. Russel NH, Hunter A, Rogers S et al. Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet 1993; 341: 1482.
3. Lemoli RM, Bandini G, Leopardi G et al. Allogeneic peripheral blood stem cell transplantation in patients with earlyphase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation. Haematologica 1998; 83: 48-55.
4. Weaver CH, Longin K, Buckner CD et al. Lymphocyte content in peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant 1994; 13: 411-415.
5. Korbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma - potential advantage of blood over marrow allografts. Blood 1995; 85: 1659-1665.
6. Bensinger WI, Weaver CH, Appelbaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilised by recombinant human granulocyte colony-stimulating factor. Blood 1995; 85: 1655-1658.
7. Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1985; 85: 1666-1672.
8. + donor T cells fail to induce experimental acute graft-versus-host disease. J Immunol 1995; 155: 585-593.
9. Pan L, Delmonte Jr J, Jalonen CK, Ferrara JLM. Pretreatment of donor mice with granulocyte colony-stimulating factor pol- arizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 1995; 86: 4422-4429.
10. Zeng D, Dejbakhsh-Jones S, Strober S. Granulocyte colony-stimulating factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: impact on blood progenitor cell transplantation. Blood 1997; 90: 453-463.
11. + cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood 1997; 89: 1629-1634.
12. + blood cells. Bone Marrow Transplant 1998; 21: 1085-1089.
13. + cells mobilized by granulocyte colony-stimulating factor. Br J Haematol 1996; 92: 788-794.
14. Kitabayashi A, Hirokawa Y, Lee M et al. Granulocyte colony-stimulating factor downregulates allogeneic immune responses by post-transcriptional inhibition of tumor necrosis factor-α production. Blood 1995; 86: 2220-2227.
15. Neubauer MA, Benyunes JA, Thompson WI et al. Lymphokine-activated killer (LAK) precursor cell activity is present in infused peripheral blood stem cells and in the blood after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1994; 13: 311-316.
16. Conte R, Tazzari PL, Bandini G et al. Deficiency of autologous mixed lymphocyte reaction in long-term bone marrow transplant recipients without clinical chronic graft-versus host disease. Haematologica 1988; 73: 297-301
17. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145-173.
18. Mowat A. Antibodies to IFN-gamma prevent immunological mediated intestinal damage in murine graft-versus-host reactions. Immunology 1989; 68: 18-23.
19. + cells. J Immunol 1995; 155 2396-2406.
20. Fowler DH, Kurasawa K, Smith R et al. Donor CD4-enriched cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice. Blood 1994; 84: 3540-3549.
21. Roberts MM, To LB, Mundy J et al. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant 1993; 12: 469-475.
22. Hartung O, Döcke WD, Gantner F et al. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 1995; 85: 2482-2489.
23. Ino K, Singh RK, Talmadge JE. Monocytes from mobilized stem cells inhibit T cell function. J Leukocyte Biol 1997; 61: 583-591.
24. Tanaka J, Mielcarek M, Torok-Storb B. Impaired induction of the CD28-responsive complex in granulocyte colony-stimulating factor mobilized CD4 T cells. Blood 1998; 91: 347-352.
25. Talmadge JE, Reed EC, Kessinger A et al. Immunologic attributes of cytokine mobilized peripheral blood cells and recovery following transplantation. Bone Marrow Transplant 1996; 17: 101-109.
26. Verbik DJ, Jackson JD, Pirruccello SJ et al. Functional and phenotypic characterization of human peripheral blood stem cell harvests: a comparative analysis of cells from consecutive collections. Blood 1995; 85: 1964-1970.
27. Miller JS, Prosper F, McCullar V. Natural killer (NK) cells are functionally abnormal and NK cell progenitors are dimin- ished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections. Blood 1997; 90: 3098-3105.
28. Talmadge JE, Reed E, Ino K et al. Rapid immunologic recon stitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. Bone Marrow Transplant 1997; 19: 161-172.
29. +, Tc1/Tc2 populations in murine GVL: type I cells generate GVL and type II abrogate GVL. Biol Blood Marrow Transplant 1996; 3: 118-125.